Heart Failure With Reduced Ejection Fraction trials recruiting in Texas

All Heart Failure With Reduced Ejection Fraction trials nationally

Cities in Texas

Recruiting trials in Texas

• Ketones, SGLT2, HFrEF
  NCT06229678 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• Left vs Left Randomized Clinical Trial
  NCT05650658 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Arlington, Houston
• Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
  NCT06831825 · Phase: Phase 1 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Houston
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Texas: Dallas, El Paso, Galveston, Houston